vs
Side-by-side financial comparison of FONAR CORP (FONR) and PCB BANCORP (PCB). Click either name above to swap in a different company.
PCB BANCORP is the larger business by last-quarter revenue ($29.2M vs $25.5M, roughly 1.1× FONAR CORP). On growth, PCB BANCORP posted the faster year-over-year revenue change (11.3% vs 2.4%). PCB BANCORP produced more free cash flow last quarter ($24.4M vs $-227.0K). Over the past eight quarters, PCB BANCORP's revenue compounded faster (10.4% CAGR vs -0.3%).
FONAR Corp is a specialized medical technology firm that designs, manufactures, and distributes innovative MRI systems including upright and open models. It primarily serves U.S. hospitals, diagnostic imaging centers, and healthcare providers, delivering high-precision scanning solutions for clinical diagnostic use.
PCB Bank is an American community bank that focuses on the Korean-American community based in California and offers commercial banking services. It has branches in 8 states and is the third largest Korean American Bank after Bank of Hope and Hanmi Bank.
FONR vs PCB — Head-to-Head
Income Statement — Q2 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $25.5M | $29.2M |
| Net Profit | $2.1M | — |
| Gross Margin | — | — |
| Operating Margin | 13.5% | 45.0% |
| Net Margin | 8.0% | — |
| Revenue YoY | 2.4% | 11.3% |
| Net Profit YoY | 4.7% | — |
| EPS (diluted) | — | $0.65 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $25.5M | $29.2M | ||
| Q3 25 | $26.0M | $30.4M | ||
| Q2 25 | $27.3M | $29.3M | ||
| Q1 25 | $27.2M | $26.9M | ||
| Q4 24 | $24.9M | $26.2M | ||
| Q3 24 | $25.0M | $25.3M | ||
| Q2 24 | $25.9M | $24.2M | ||
| Q1 24 | $25.7M | $23.9M |
| Q4 25 | $2.1M | — | ||
| Q3 25 | $2.3M | $11.4M | ||
| Q2 25 | $729.3K | $9.1M | ||
| Q1 25 | $2.5M | $7.7M | ||
| Q4 24 | $2.0M | — | ||
| Q3 24 | $3.1M | $7.8M | ||
| Q2 24 | $830.4K | $6.3M | ||
| Q1 24 | $1.9M | $4.7M |
| Q4 25 | 13.5% | 45.0% | ||
| Q3 25 | 14.1% | 52.3% | ||
| Q2 25 | 5.3% | 43.3% | ||
| Q1 25 | 15.2% | 40.2% | ||
| Q4 24 | 11.9% | 39.3% | ||
| Q3 24 | 21.0% | 42.2% | ||
| Q2 24 | 7.4% | 36.3% | ||
| Q1 24 | 16.8% | 27.2% |
| Q4 25 | 8.0% | — | ||
| Q3 25 | 8.7% | 37.5% | ||
| Q2 25 | 2.7% | 31.0% | ||
| Q1 25 | 9.2% | 28.8% | ||
| Q4 24 | 7.9% | — | ||
| Q3 24 | 12.6% | 30.8% | ||
| Q2 24 | 3.2% | 25.9% | ||
| Q1 24 | 7.3% | 19.6% |
| Q4 25 | — | $0.65 | ||
| Q3 25 | — | $0.78 | ||
| Q2 25 | — | $0.62 | ||
| Q1 25 | — | $0.53 | ||
| Q4 24 | — | $0.46 | ||
| Q3 24 | — | $0.52 | ||
| Q2 24 | — | $0.43 | ||
| Q1 24 | — | $0.33 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $121.0K | $207.1M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $176.9M | $390.0M |
| Total Assets | $217.2M | $3.3B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $121.0K | $207.1M | ||
| Q3 25 | $122.0K | $369.5M | ||
| Q2 25 | $56.5M | $263.6M | ||
| Q1 25 | $123.0K | $214.3M | ||
| Q4 24 | $121.0K | $198.8M | ||
| Q3 24 | $136.0K | $193.1M | ||
| Q2 24 | $56.5M | $177.6M | ||
| Q1 24 | $134.0K | $239.8M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | $66.9K | — | ||
| Q1 24 | — | — |
| Q4 25 | $176.9M | $390.0M | ||
| Q3 25 | $174.9M | $384.5M | ||
| Q2 25 | $172.6M | $376.5M | ||
| Q1 25 | $171.9M | $370.9M | ||
| Q4 24 | $169.8M | $363.8M | ||
| Q3 24 | $168.7M | $362.3M | ||
| Q2 24 | $166.0M | $353.5M | ||
| Q1 24 | $165.8M | $350.0M |
| Q4 25 | $217.2M | $3.3B | ||
| Q3 25 | $218.4M | $3.4B | ||
| Q2 25 | $216.9M | $3.3B | ||
| Q1 25 | $214.9M | $3.2B | ||
| Q4 24 | $208.0M | $3.1B | ||
| Q3 24 | $212.3M | $2.9B | ||
| Q2 24 | $214.2M | $2.9B | ||
| Q1 24 | $209.6M | $2.9B |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 0.00× | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $171.0K | $26.6M |
| Free Cash FlowOCF − Capex | $-227.0K | $24.4M |
| FCF MarginFCF / Revenue | -0.9% | 83.6% |
| Capex IntensityCapex / Revenue | 1.6% | 7.5% |
| Cash ConversionOCF / Net Profit | 0.08× | — |
| TTM Free Cash FlowTrailing 4 quarters | $5.7M | $46.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $171.0K | $26.6M | ||
| Q3 25 | $1.7M | $16.4M | ||
| Q2 25 | $4.2M | $4.9M | ||
| Q1 25 | $3.1M | $2.3M | ||
| Q4 24 | $2.2M | $39.0M | ||
| Q3 24 | $1.7M | $11.9M | ||
| Q2 24 | $4.6M | $14.6M | ||
| Q1 24 | $2.8M | $8.2M |
| Q4 25 | $-227.0K | $24.4M | ||
| Q3 25 | $-177.0K | $16.2M | ||
| Q2 25 | $3.6M | $3.8M | ||
| Q1 25 | $2.6M | $1.6M | ||
| Q4 24 | $1.5M | $34.9M | ||
| Q3 24 | $-148.0K | $11.9M | ||
| Q2 24 | $4.2M | $12.8M | ||
| Q1 24 | $2.6M | $6.0M |
| Q4 25 | -0.9% | 83.6% | ||
| Q3 25 | -0.7% | 53.2% | ||
| Q2 25 | 13.1% | 13.1% | ||
| Q1 25 | 9.4% | 6.0% | ||
| Q4 24 | 6.0% | 133.2% | ||
| Q3 24 | -0.6% | 46.8% | ||
| Q2 24 | 16.1% | 53.1% | ||
| Q1 24 | 10.2% | 25.2% |
| Q4 25 | 1.6% | 7.5% | ||
| Q3 25 | 7.2% | 0.8% | ||
| Q2 25 | 2.4% | 3.7% | ||
| Q1 25 | 2.2% | 2.8% | ||
| Q4 24 | 3.0% | 15.5% | ||
| Q3 24 | 7.2% | 0.1% | ||
| Q2 24 | 1.6% | 7.3% | ||
| Q1 24 | 0.7% | 9.3% |
| Q4 25 | 0.08× | — | ||
| Q3 25 | 0.75× | 1.44× | ||
| Q2 25 | 5.79× | 0.54× | ||
| Q1 25 | 1.26× | 0.30× | ||
| Q4 24 | 1.14× | — | ||
| Q3 24 | 0.53× | 1.52× | ||
| Q2 24 | 5.54× | 2.33× | ||
| Q1 24 | 1.50× | 1.76× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FONR
| Managementof Diagnostic Imaging Centers | $23.2M | 91% |
| Manufacturingand Servicingof Medical Equipment | $2.4M | 9% |
PCB
Segment breakdown not available.
